Elisabeth M.
- Country
- France
- Department
- Departement de neurologie
Research Overview
- A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION OF RELAPSE IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY ASSOCIATED DISEASE (MOG-AD) AFTER A FIRST ATTACK : MOGWAI
- Evaluation of Ofatumumab Concentration in Breast Milk of Lactating Women with Relapsing Multiple Sclerosis Receiving Ofatumumab Therapy
- Phase 3 Extension Study on Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 120 of 253 partner sites.
Specializations
Multiple Sclerosis Management
This investigator specializes in treating various forms of multiple sclerosis, with particular focus on relapsing-remitting MS and progressive MS variants. Their research encompasses both established and innovative therapeutic approaches.
- Relapsing Forms of MS Treatment
- Progressive MS Interventions
- Age-Specific Treatment Strategies
The investigator evaluates treatment effectiveness in different MS patient populations, including specific considerations for older adults.
Neurological Therapeutics
Their expertise extends to investigating novel therapeutic agents for neurological conditions, particularly focusing on BTK inhibitors and monoclonal antibody treatments. The research includes evaluation of innovative compounds for managing neurological disorders.
- Novel Drug Development
- Treatment Safety Assessment
- Long-term Therapeutic Outcomes
The investigator explores both established and experimental therapeutic approaches in neurology.
Specialized Patient Care
Research initiatives include studies on treatment optimization for specific patient groups, including investigations into medication safety during lactation and specialized approaches for nonrelapsing progressive conditions.
- Targeted Treatment Protocols
- Patient-Specific Care Approaches
- Treatment Safety Monitoring
Their work emphasizes individualized treatment strategies for diverse patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.